The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis

ADAM15 在前列腺肿瘤浸润和转移中的作用

基本信息

  • 批准号:
    8256675
  • 负责人:
  • 金额:
    $ 39.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-06-21 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have been investigating the function of the ADAM15 disintegrin in the metastatic progression of human prostate cancer. This work is based on biological models of human prostate tumor growth, prostate tumor cell/vascular endothelial interactions, angiogenesis, angioinvasion and overt metastasis, which demonstrates a clear, but uncharacterized role for ADAM15 in prostate cancer progression. Our preliminary studies supports the central hypothesis that aberrant ADAM15 function in prostate tumor cells not only supports primary tumor growth, but also mediates interactions between prostate tumor cells and vascular endothelium promoting vascular intravazation and metastasis. The primary goals of this proposal will attempt to delineate the specific function of ADAM15 in these malignant processes. The mechanistically focused experiments we describe should confirm that ADAM15 functions in metastatic processes that are relevant to human prostate cancer. Consequently, this project is of direct relevance to human health. If ADAM15 can be validated as a mediator of metastatic progression of prostate cancer, then a rationale for targeting ADAM15 therapeutically would be justified. Several members of the ADAM family, including ADAM15 are emerging as regulators of the tumor microenvironment and interest in their potential as targets for the development of anticancer agents is rising. Given the diversity of ADAM15 functional domains, this disintegrin is thought to affect several important cellular processes that are intrinsic to cancer and its metastatic spread. Modalities aimed at inhibiting the extracellular activation of ADAM15 metalloproteinase activity or its EGF-homology or disintegrin domains could prove beneficial for the treatment of metastatic prostate cancer. PUBLIC HEALTH RELEVANCE: Given the diversity of ADAM15 functional domains, this disintegrin is thought to effect several important cellular processes that are intrinsic to prostate cancer and its metastatic spread. Modalities aimed at inhibiting the extracellular metalloproteinase domain, the EGF-homology domain or the disintegrin domain could prove beneficial for the treatment of metastatic prostate cancer.
描述(由申请人提供):我们一直在研究ADAM 15去整合素在人前列腺癌转移进展中的功能。这项工作是基于人前列腺肿瘤生长,前列腺肿瘤细胞/血管内皮相互作用,血管生成,血管侵袭和明显转移的生物模型,这表明了一个明确的,但未表征的作用,ADAM 15在前列腺癌的进展。我们的初步研究支持了一个中心假设,即在前列腺肿瘤细胞中异常的ADAM 15功能不仅支持原发性肿瘤的生长,而且介导前列腺肿瘤细胞和血管内皮之间的相互作用,促进血管内流和转移。本提案的主要目标将试图描绘在这些恶性过程中的特定功能的ADAM 15。我们所描述的机械聚焦实验应该证实,ADAM 15在与人类前列腺癌相关的转移过程中发挥作用。因此,该项目与人类健康直接相关。如果ADAM 15可以被验证为前列腺癌转移进展的介导物,那么治疗靶向ADAM 15的理由将是合理的。ADAM家族的几个成员,包括ADAM 15正在成为肿瘤微环境的调节剂,并且对它们作为抗癌剂开发靶点的潜力的兴趣正在上升。考虑到ADAM 15功能结构域的多样性,这种去整合素被认为影响癌症及其转移扩散固有的几个重要细胞过程。旨在抑制ADAM 15金属蛋白酶活性或其EGF同源性或去整合素结构域的细胞外活化的方法可以证明对转移性前列腺癌的治疗有益。 公共卫生关系:鉴于ADAM 15功能结构域的多样性,这种去整合素被认为影响前列腺癌及其转移性扩散固有的几个重要细胞过程。旨在抑制细胞外金属蛋白酶结构域、EGF同源结构域或去整合素结构域的方式可以证明对转移性前列腺癌的治疗有益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK L DAY其他文献

MARK L DAY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK L DAY', 18)}}的其他基金

Delineation of tumor, stromal and immune transcriptomes at the infiltrating interface of muscle invasive bladder cancer
肌肉浸润性膀胱癌浸润界面的肿瘤、基质和免疫转录组的描绘
  • 批准号:
    10543535
  • 财政年份:
    2021
  • 资助金额:
    $ 39.71万
  • 项目类别:
Delineation of tumor, stromal and immune transcriptomes at the infiltrating interface of muscle invasive bladder cancer
肌肉浸润性膀胱癌浸润界面的肿瘤、基质和免疫转录组的描绘
  • 批准号:
    10353062
  • 财政年份:
    2021
  • 资助金额:
    $ 39.71万
  • 项目类别:
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
ADAM15 在前列腺肿瘤浸润和转移中的作用
  • 批准号:
    8096777
  • 财政年份:
    2010
  • 资助金额:
    $ 39.71万
  • 项目类别:
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
ADAM15 在前列腺肿瘤浸润和转移中的作用
  • 批准号:
    8460156
  • 财政年份:
    2010
  • 资助金额:
    $ 39.71万
  • 项目类别:
The Role of ADAM15 in Prostate Tumor Intravazation and Metastasis
ADAM15 在前列腺肿瘤浸润和转移中的作用
  • 批准号:
    8658029
  • 财政年份:
    2010
  • 资助金额:
    $ 39.71万
  • 项目类别:
University of Michigan O'Brien Center for Urology Research
密歇根大学奥布莱恩泌尿学研究中心
  • 批准号:
    7500607
  • 财政年份:
    2007
  • 资助金额:
    $ 39.71万
  • 项目类别:
University of Michigan O'Brien Center for Urology Research
密歇根大学奥布莱恩泌尿学研究中心
  • 批准号:
    7500605
  • 财政年份:
    2007
  • 资助金额:
    $ 39.71万
  • 项目类别:
Rb/E2F in Hormone signaling of Prostate Epithelium
前列腺上皮激素信号传导中的 Rb/E2F
  • 批准号:
    7053355
  • 财政年份:
    2004
  • 资助金额:
    $ 39.71万
  • 项目类别:
Rb/E2F in Hormone signaling of Prostate Epithelium
前列腺上皮激素信号传导中的 Rb/E2F
  • 批准号:
    6881046
  • 财政年份:
    2004
  • 资助金额:
    $ 39.71万
  • 项目类别:
Rb/E2F in Hormone Signaling of Prostate Epithelium
前列腺上皮激素信号转导中的 Rb/E2F
  • 批准号:
    6704381
  • 财政年份:
    2004
  • 资助金额:
    $ 39.71万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 39.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了